Sami Pervaiz
Pulmonary Disease · Brooklyn, NYNPI 1528592631
Payments from drug & device makers
Across 223 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$869
- Phathom Pharmaceuticals, Inc.$367
- Johnson & Johnson$250
- Actelion Pharmaceuticals US, Inc.$208
- Boehringer Ingelheim$159
- plus $878 from 15 others
What the payments were for
- Food & beverage$4,67298%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 96 | $2,041 |
| GSK | 57 | $869 |
| Phathom Pharmaceuticals, Inc. | 22 | $367 |
| Johnson & Johnson | 2 | $250 |
| Actelion Pharmaceuticals US, Inc. | 5 | $208 |
| Boehringer Ingelheim | 4 | $159 |
| Exact Sciences | 6 | $149 |
| Sanofi | 5 | $123 |
| Verona Pharma, Inc. | 4 | $104 |
| Amgen | 5 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $45 |
| Viatris Specialty LLC | 2 | $45 |
| Philips North America LLC | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $26 |
| Baxter Healthcare | 1 | $26 |
| Electromed, Inc. | 1 | $25 |
| Medicomp Inc | 1 | $25 |
| Insmed, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,772 in reported general payments places this provider in the 70th percentile of 1,115 pulmonary disease providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 96 | $84,990 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 95 | $73,573 |
| OzempicSemaglutide | 41 | $44,010 |
| MounjaroTirzepatide | 24 | $28,743 |
| JardianceEmpagliflozin | 31 | $27,784 |
| JanuviaSitagliptin Phosphate | 15 | $13,447 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $10,092 |
| AirsupraAlbuterol Sulfate/Budesonide | 13 | $9,027 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 20 | $4,093 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 83 | $2,392 |
| Azelastine Hcl | 108 | $2,183 |
| Diclofenac Sodium ErDiclofenac Sodium | 23 | $1,979 |
| Diclofenac Sodium | 19 | $1,885 |
| Naproxen Sodium | 16 | $1,618 |
| Fluticasone Propionate | 115 | $1,086 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Airsupra | $2,041 | $94,016109 claims |
| GSKTrelegy Ellipta | $869 | $73,57395 claims |
| Lilly USA, LLCMounjaro | $45 | $28,74324 claims |
| Boehringer IngelheimJardiance | $159 | $27,78431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,115 pulmonary disease providers in New York.
Other pulmonary disease in Brooklyn
- Ali El AtatBrooklyn$547K
- Sunil MehraBrooklyn$388K
- Aaliya BurzaBrooklyn$334K
- Xiaojun YanBrooklyn$249K
- Linda RogersNew York$7.1M
- Maria PadillaNew York$3.6M
- R WhiteRochester$3.1M
- Juan WisniveskyNew York$3M
- Bushra MinaNew York$2.5M
- Robert KanerNew York$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.